First Turn Management »

United Therapeutics Corporation shares owned by First Turn Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $36M 85k 419.21

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation